Cochrane · systematic review · CD011745
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
Taverny, G, Mimouni, Y, LeDigarcher, A, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library
HypertensionAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 3 · 100%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antihypertensive pharmacotherapy versus control for prevention of sudden cardiac death in hypertensive individuals
Population: people with hypertension (defined as baseline systolic resting blood pressure ≥ 140 mmHg and/or resting diastolic blood pressure ≥ 90 mmHg)
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Sudden cardiac death ( Antihypertensive pharmacotherapy vs control | RR 0.96 [0.81, 1.15] | 15 studies · 39908 participants | Moderate Downgraded: imprecision |
Non‐fatal myocardial infarction ( Antihypertensive pharmacotherapy vs control | RR 0.85 [0.74, 0.98] | 15 studies · 39908 participants | Moderate Downgraded: imprecision |
Fatal myocardial infarction ( Antihypertensive pharmacotherapy vs control | RR 0.75 [0.62, 0.9] | 15 studies · 39908 participants | Moderate Downgraded: imprecision |